ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

How Urologists Detect Bladder Cancer With Blue Light Cystoscopy

photo

SPONSORED CONTENT -- (StatePoint) Like many bladder cancer survivors, Karen S. often reflects on her personal experience with the disease, and the support she received throughout her healthcare journey.

Karen was diagnosed with bladder cancer in 2010 at age 54, after experiencing symptoms for two years. As an oncology nurse for more than 40 years, she was well aware of the many forms of cancer. Nevertheless, she assumed her frequent urinary tract infections and discomfort were gynecological in nature and never expected her doctors to discover a tumor or to be diagnosed with bladder cancer.

After receiving a variety of medical treatments, Karen still had persistent disease. She transferred to a National Cancer Institute-designated cancer center where her bladder cancer specialist informed her about a technology called Blue Light Cystoscopy (BLC) that would allow her doctor to see tumors that white light alone may miss.

“BLC was a quick and easy procedure that gave my doctor the ability to identify tumors early on, allowing for earlier and less aggressive treatment,” says Karen.

Each year, about 81,000 people in the United States are diagnosed with bladder cancer, according to the National Cancer Institute. Symptoms in both men and women can mimic common urinary tract infections, like they did for Karen. For men, however, the more common symptom is blood in the urine. Whatever the symptoms, it is important to see a doctor.

According to Karen, people with bladder cancer, or those who suspect they may have bladder cancer, should ask their doctor questions and seek a second opinion. Once diagnosed, they should explore support groups and do research on bladder cancer, including learning about the latest treatments and technologies available.

“It’s especially important for me to inform others about the benefits of BLC, since many people may not be aware of this option. BLC may help others diagnosed with bladder cancer the way it helped me,” says Karen.

A cystoscopy is a medical procedure where a urology healthcare professional uses a thin, tube-like telescope called a cystoscope to look directly into the bladder for a close examination of the lining. This procedure is used to help find the cause of symptoms and to treat and monitor the condition. Historically, the only type of cystoscopy available used white light. BLC, however, uses both white and blue light to offer significantly improved detection of suspicious areas compared to white light alone and has been proven to increase the detection of non-muscle invasive bladder cancer.

Today, Karen is cancer free and continues to support those affected by bladder cancer, including patients, caregivers and their loved ones, by hosting support groups and working with the Bladder Cancer Advocacy Network. These resources can be found by visiting https://bcan.org/.

People experiencing symptoms of bladder cancer and those who have been recently diagnosed should ask their urologist about BLC, because it’s not available everywhere. To search for a location where BLC is offered near you, visit https://rebrand.ly/BLC-Locator.

This article is sponsored by Photocure Inc.

Photo Credit: (c) fizkes / iStock via Getty Images Plus

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.